NRSF/REST neuronal deficient mice are more vulnerable to the neurotoxin MPTP.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Neurobiology of Aging

• Publication date

  2013-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.neurobiolaging.2012.06.002PMID 22766071
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin‐induced damage

  2012cited by this paper
• Repressor element-1 silencing transcription factor (REST)-dependent epigenetic remodeling is critical to ischemia-induced neuronal death

  2012cited by this paper
• Ethanol-induced neurodegeneration in NRSF/REST neuronal conditional knockout mice.

  2011cited by this paper
• Protective effects of valproic acid on the nigrostriatal dopamine system in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

  2011cited by this paper
• The Master Negative Regulator REST/NRSF Controls Adult Neurogenesis by Restraining the Neurogenic Program in Quiescent Stem Cells

  2011cited by this paper
• Conditional deletion of NRSF in forebrain neurons accelerates epileptogenesis in the kindling model.

  2011cited by this paper
• Gene expression profiling in progressively MPTP-lesioned macaques reveals molecular pathways associated with sporadic Parkinson's disease.

  2010cited by this paper
• Epigenetic Gene Silencing Underlies C-Fiber Dysfunctions in Neuropathic Pain

  2010cited by this paper
• Aging enhances the neuroinflammatory response and alpha-synuclein nitration in rats.

  2010cited by this paper
• Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia.

  2010cited by this paper
• Corepressor for element-1–silencing transcription factor preferentially mediates gene networks underlying neural stem cell fate decisions

  2010cited by this paper
• Differential Deployment of REST and CoREST Promotes Glial Subtype Specification and Oligodendrocyte Lineage Maturation

  2009cited by this paper
• REST and CoREST Modulate Neuronal Subtype Specification, Maturation and Maintenance

  2009cited by this paper
• Elevated interleukin-1beta induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine aggravating dopaminergic neurodegeneration in old male mice.

  2009cited by this paper
• Alteration of NRSF expression exacerbating 1-methyl-4-phenyl-pyridinium ion-induced cell death of SH-SY5Y cells.

  2009cited by this paper
• Expression of Cbl-interacting protein of 85 kDa in MPTP mouse model of Parkinson's disease and 1-methyl-4-phenyl-pyridinium ion-treated dopaminergic SH-SY5Y cells.

  2008cited by this paper
• Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease.

  2007cited by this paper
• Widespread Disruption of Repressor Element-1 Silencing Transcription Factor/Neuron-Restrictive Silencer Factor Occupancy at Its Target Genes in Huntington's Disease

  2007cited by this paper
• The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation

  2007cited by this paper
• Regulation and role of REST and REST4 variants in modulation of gene expression in in vivo and in vitro in epilepsy models.

  2006cited by this paper
• Behavioral models of Parkinson's disease in rodents: A new look at an old problem

  2006cited by this paper
• Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease.

  2006cited by this paper
• Gene Expression Profiling of Sporadic Parkinson's Disease Substantia Nigra Pars Compacta Reveals Impairment of Ubiquitin‐Proteasome Subunits, SKP1A, Aldehyde Dehydrogenase, and Chaperone HSC‐70

  2005cited by this paper
• Striatal trophic factor activity in aging monkeys with unilateral MPTP-induced parkinsonism.

  2005cited by this paper
• Genome-wide analysis of repressor element 1 silencing transcription factor/neuron-restrictive silencing factor (REST/NRSF) target genes.

  2004cited by this paper
• Neuroprotective mechanism of modafinil on Parkinson disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  2004cited by this paper
• Ischemic Insults Derepress the Gene Silencer REST in Neurons Destined to Die

  2003cited by this paper
• The mouse MPTP model: gene expression changes in dopaminergic neurons

  2003cited by this paper
• Time-course of the expression of inflammatory cytokines and matrix metalloproteinases in the striatum and mesencephalon of mice injected with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a dopaminergic neurotoxin.

  2003cited by this paper
• Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes

  2003cited by this paper
• Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down's syndrome: a gene expression study.

  2002cited by this paper
• Inflammation in Parkinson's disease.

  2001cited by this paper
• Inflammation in Parkinson's disease.

  2001cited by this paper
• Differential expression of GDNF, BDNF, and NT-3 in the aging nigrostriatal system following a neurotoxic lesion.

  2001cited by this paper
• Lesion-induced increase of BDNF is greater in the striatum of young versus old rat brain.

  2000cited by this paper
• Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration.

  2000cited by this paper
• Neural restrictive silencer factor recruits mSin3 and histone deacetylase complex to repress neuron-specific target genes.

  1999cited by this paper
• FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells.

  1999cited by this paper
• Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine exposure

  1999cited by this paper
• FcεRII/CD23 Is Expressed in Parkinson’s Disease and Induces, In Vitro, Production of Nitric Oxide and Tumor Necrosis Factor-α in Glial Cells

  1999cited by this paper
• Neuronal Expression of Zinc Finger Transcription Factor REST/NRSF/XBR Gene

  1998cited by this paper
• NRSF/REST is required in vivo for repression of multiple neuronal target genes during embryogenesis

  1998cited by this paper
• Molecular profile of reactive astrocytes—Implications for their role in neurologic disease

  1993cited by this paper
• A new motor test sensitive to aging and dopaminergic function.

  1991cited by this paper

• REST Is Restless in Neuronal and Non-Neuronal Virus Infections: An In Silico Analysis-Based Perspective

  2025cites this paper
• Tamoxifen attenuates manganese-induced dysregulation of neuronal REST via the genomic ER-α mechanism

  2025cites this paper
• Dopaminergic REST/NRSF is protective against manganese-induced neurotoxicity in mice

  2024influential citation
• Interplay of MeCP2/ REST/ Synaptophysin-BDNF and intranasal oxytocin influence on Aβ-induced memory and cognitive impairments.

  2024cites this paper
• Thymopentin (TP-5) prevents lipopolysaccharide-induced neuroinflammation and dopaminergic neuron injury by inhibiting the NF-κB/NLRP3 signaling pathway.

  2023cites this paper
• TLR2 deficiency is beneficial at the late phase in MPTP-induced Parkinson's disease mice.

  2023cites this paper
• REST Is Not Resting: REST/NRSF in Health and Disease

  2023cites this paper
• REST in the Road Map of Brain Development

  2023cites this paper
• Repressor Element-1 Binding Transcription Factor (REST) as a Possible Epigenetic Regulator of Neurodegeneration and MicroRNA-Based Therapeutic Strategies

  2023cites this paper
• NRSF regulates age-dependently cognitive ability and its conditional knockout in APP/PS1 mice moderately alters ad-like pathology.

  2022cites this paper
• Roles of the Neuron-Restrictive Silencer Factor in the Pathophysiological Process of the Central Nervous System

  2022cites this paper
• Pharmaceutical Considerations of Translabial Formulations for Treatment of Parkinson's Disease: A Concept of Drug Delivery for Unconscious Patients.

  2022cites this paper
• Deletion of RE1‐silencing transcription factor in striatal astrocytes exacerbates manganese‐induced neurotoxicity in mice

  2022cites this paper
• The functions of repressor element 1-silencing transcription factor in models of epileptogenesis and post-ischemia

  2021cites this paper
• Astrocytic transcription factor REST upregulates glutamate transporter EAAT2, protecting dopaminergic neurons from manganese-induced excitotoxicity

  2021cites this paper
• Effect of 9 - PAHSA on cognitive dysfunction in diabetic mice and its possible mechanism.

  2020cites this paper
• Study of Microglial and Astroglial Alterations Induced by Acute 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Treatment in Mouse Brain

  2020cites this paper
• The transcription factor REST up-regulates tyrosine hydroxylase and antiapoptotic genes and protects dopaminergic neurons against manganese toxicity

  2020influential citation
• [Brain and Neuronal Aging: Aged Brain Controls via Gene Expression Fidelity and Master Regulatory Factors].

  2020cites this paper
• Spatiotemporal immunolocalisation of REST in the brain of healthy ageing and Alzheimer’s disease rats

  2020cites this paper
• Epigenetic Modification and Retinal Degeneration: Evidence of New Potential Therapeutic Targets

  2020cites this paper
• Enhancement of oral bioavailability and anti-Parkinsonian efficacy of resveratrol through a nanocrystal formulation

  2019cites this paper
• Dysregulation in the Brain Protein Profile of Zebrafish Lacking the Parkinson’s Disease-Related Protein DJ-1

  2019cites this paper
• Ablation of RIP3 protects from dopaminergic neurodegeneration in experimental Parkinson’s disease

  2019cites this paper
• The deficiency of NRSF/REST enhances the pro-inflammatory function of astrocytes in the model of Parkinson's disease.

  2019cites this paper
• Brain-specific NRSF deficiency aggravates dopaminergic neurodegeneration and impairs neurogenesis in the MPTP mouse model of Parkinson’s disease

  2019cites this paper
• Alpha‐synuclein at the nexus of genes and environment: the impact of environmental enrichment and stress on brain health and disease

  2019cites this paper
• /Calmodulin dependent protein kinase IV on REST activity

  2019cites this paper
• Dl-3-n-Butylphthalide Exerts Dopaminergic Neuroprotection Through Inhibition of Neuroinflammation

  2019cites this paper
• REST: An epigenetic regulator of neuronal stress responses in the young and ageing brain.

  2019cites this paper
• REST, not REST4, is a risk factor associated with radiotherapy plus chemotherapy efficacy in glioma

  2018cites this paper
• RESP18 deficiency has protective effects in dopaminergic neurons in an MPTP mouse model of Parkinson's disease

  2018cites this paper
• Inhibition of the Epigenetic Regulator REST Ameliorates Ischemic Brain Injury

  2018cites this paper
• Gene Therapy for Parkinson’s Disease, An Update

  2018cites this paper
• Long-term Changes in the Nigrostriatal Pathway in the MPTP Mouse Model of Parkinson's Disease.

  2018cites this paper
• REST, a master transcriptional regulator in neurodegenerative disease.

  2018cites this paper
• The emerging field of epigenetics in neurodegeneration and neuroprotection

  2017cites this paper
• Examining an Animal Model of Depression with Recurrent Depression-like Episodes

  2017cites this paper
• Dynamic Changes in the Nigrostriatal Pathway in the MPTP Mouse Model of Parkinson's Disease

  2017cites this paper
• Running for REST: Physical activity attenuates neuroinflammation in the hippocampus of aged mice.

  2017cites this paper
• The emerging field of epigenetics in neurodegeneration and neuroprotection

  2017cites this paper
• Erythropoietin Signaling Regulates Key Epigenetic and Transcription Networks in Fetal Neural Progenitor Cells

  2017cites this paper
• REST and the regulation of stress resistance, brain aging, and Alzheimer’s disease

  2016cites this paper
• The Transcription Repressor REST in Adult Neurons: Physiology, Pathology, and Diseases,,

  2015cites this paper
• Rest mutant zebrafish swim erratically and display atypical spatial preferences.

  2015cites this paper
• NRSF is an essential mediator for the neuroprotection of trichostatin A in the MPTP mouse model of Parkinson's disease.

  2015influential citation
• REST and Stress Resistance in Aging and Alzheimer’s Disease

  2014cites this paper
• A survey from 2012 of evidence for the role of neuroinflammation in neurotoxin animal models of Parkinson's disease and potential molecular targets.

  2014cites this paper
• Parkin overexpression ameliorates hippocampal long-term potentiation and β-amyloid load in an Alzheimer's disease mouse model.

  2014cites this paper
• The tumor suppressor microRNA, miR-124a, is regulated by epigenetic silencing and by the transcriptional factor, REST in glioblastoma

  2014cites this paper
• REST and Stress Resistance in Ageing and Alzheimer’s Disease you. Your

  2014cites this paper
• NRSF: an Angel or a Devil in Neurogenesis and Neurological Diseases

  2014cites this paper
• RE-1 silencing transcription factor (REST): a regulator of neuronal development and neuronal/endocrine function

  2014cites this paper
• Expression and function of the dense‐core vesicle membranes are governed by the transcription repressor REST

  2013cites this paper
• Increases in the Risk of Cognitive Impairment and Alterations of Cerebral β-amyloid Metabolism in Mouse Model of Heart Failure

  2013cites this paper